Zhenzhen Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhenzhen Zhao has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Wenyang Nie
3 shared publicationsGaofeng Ni
Department of Breast Surgery, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
2 shared publications- Hongyan Zang
Department of Breast Surgery, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
2 shared publications - Hua Li
Department of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China
2 shared publications - Wenwu Li
Department of Burn Plastic and Wound Repair Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
2 shared publications Xinhan Li
The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 170
Exploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches
Atherosclerosis is a complex chronic inflammatory disease characterized by lipid accumulation, vascular smooth muscle cell (VSMCs) proliferation, and immune cell infiltration. However, the heterogeneity and functional dynamics of VSMCs in atherosclerotic lesions have not been systematically elucidated. In this study, we integrated single-cell transcriptomics with spatial transcriptomics analysis to delineate the developmental trajectories and functional states of VSMC subsets. Our analysis identified a distinct LUM + VSMCs subpopulation residing at an early stage of differentiation, marked by elevated cellular plasticity, stemness features, and strong activation of pro-inflammatory signaling pathways. Spatial transcriptomics and in vitro functional assays—including EdU incorporation, apoptosis quantification, and cell viability assays—further validated LUM as a key regulator promoting VSMC proliferation and inflammation. Importantly, the C0 LUM + VSMCs were predicted to interact extensively with endothelial cells and macrophages through CD99, MIF, and CCL-mediated signaling axes, underscoring their role as dedifferentiated, pro-inflammatory effector cells contributing to disease progression. These findings highlight the power of big data-enabled single-cell approaches in identifying cell-type–specific mechanisms and offer new avenues for precision diagnostics and biomarker discovery in inflammatory vascular diseases.
- 25 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 170
Open AccessExploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches
Atherosclerosis is a complex chronic inflammatory disease characterized by lipid accumulation, vascular smooth muscle cell (VSMCs) proliferation, and immune cell infiltration. However, the heterogeneity and functional dynamics of VSMCs in atherosclerotic lesions have not been systematically elucidated. In this study, we integrated single-cell transcriptomics with spatial transcriptomics analysis to delineate the developmental trajectories and functional states of VSMC subsets. Our analysis identified a distinct LUM + VSMCs subpopulation residing at an early stage of differentiation, marked by elevated cellular plasticity, stemness features, and strong activation of pro-inflammatory signaling pathways. Spatial transcriptomics and in vitro functional assays—including EdU incorporation, apoptosis quantification, and cell viability assays—further validated LUM as a key regulator promoting VSMC proliferation and inflammation. Importantly, the C0 LUM + VSMCs were predicted to interact extensively with endothelial cells and macrophages through CD99, MIF, and CCL-mediated signaling axes, underscoring their role as dedifferentiated, pro-inflammatory effector cells contributing to disease progression. These findings highlight the power of big data-enabled single-cell approaches in identifying cell-type–specific mechanisms and offer new avenues for precision diagnostics and biomarker discovery in inflammatory vascular diseases.
- Open Access
- 1 January 2026
- Published by Compuscript, Ltd. in BIO Integration
- Vol. 7 (1)
Single-Cell Immune Microenvironment Atlas of Human Myocardial Infarction Focusing on Myeloid Cells and Functional Differentiation of Macrophage Subtypes
Background: Myocardial infarction (MI) is characterized by extensive immune activation and dynamic remodeling of the cardiac microenvironment, in which myeloid cells play critical roles in regulating inflammation and tissue repair. However, the cellular heterogeneity, developmental trajectories, and intercellular communication networks of myeloid cell subtypes during MI remain incompletely understood. Methods: Single-cell RNA sequencing (scRNA-seq) data from MI tissues were integrated to construct a comprehensive immune atlas. Cell clustering, differential expression, cell cycle, and functional enrichment analyses were performed to characterize cellular composition and biological functions. CytoTRACE, Monocle2, and Slingshot were applied to investigate macrophage differentiation trajectories, whereas transcriptional regulatory network analysis and CellChat were used to identify regulatory modules and intercellular communication pathways. Results: A total of 44,574 high-quality cells comprising 24 cell types were identified, which revealed prominent myeloid cell accumulation and enhanced immune activation in infarcted tissues. Macrophages were enriched in infarcted regions and exhibited increased proliferative activity and immune-related pathway activation. Four transcriptionally distinct macrophage subtypes were identified (C0 GPNMB + , C1 S100A4 + , C2 IL1B + , and C3 EGR1 + ), among which C 1 S100A4 + macrophages predominated, displayed the strongest proliferative ability, and expressed high levels of inflammatory mediators, including IL1B, CCL3, and CXCL8. Trajectory and regulatory analyses revealed dynamic macrophage differentiation and subtype-specific transcriptional programs. Cell-cell communication analysis identified C1 S100A4 + macrophages as a central signaling hub interacting with endothelial cells, fibroblasts, and immune cells through CXCL, MHC-II, and TNF pathways, thereby suggesting their critical role in post-MI inflammatory remodeling. Conclusion: This study provided a comprehensive single-cell immune atlas of MI and systematically elucidated the heterogeneity, developmental dynamics, transcriptional regulation, metabolic reprogramming, and intercellular communication of macrophage subtypes. C1 S100A4 + macrophages were identified as a key inflammatory population orchestrating immune remodeling after MI. Our findings provide insights into the cellular mechanisms underlying cardiac injury that may offer potential therapeutic targets for precision immunomodulation in MI.
- 1 January 2026
- Published by Compuscript, Ltd. in BIO Integration
- Vol. 7 (1)
Open AccessSingle-Cell Immune Microenvironment Atlas of Human Myocardial Infarction Focusing on Myeloid Cells and Functional Differentiation of Macrophage Subtypes
Background: Myocardial infarction (MI) is characterized by extensive immune activation and dynamic remodeling of the cardiac microenvironment, in which myeloid cells play critical roles in regulating inflammation and tissue repair. However, the cellular heterogeneity, developmental trajectories, and intercellular communication networks of myeloid cell subtypes during MI remain incompletely understood. Methods: Single-cell RNA sequencing (scRNA-seq) data from MI tissues were integrated to construct a comprehensive immune atlas. Cell clustering, differential expression, cell cycle, and functional enrichment analyses were performed to characterize cellular composition and biological functions. CytoTRACE, Monocle2, and Slingshot were applied to investigate macrophage differentiation trajectories, whereas transcriptional regulatory network analysis and CellChat were used to identify regulatory modules and intercellular communication pathways. Results: A total of 44,574 high-quality cells comprising 24 cell types were identified, which revealed prominent myeloid cell accumulation and enhanced immune activation in infarcted tissues. Macrophages were enriched in infarcted regions and exhibited increased proliferative activity and immune-related pathway activation. Four transcriptionally distinct macrophage subtypes were identified (C0 GPNMB + , C1 S100A4 + , C2 IL1B + , and C3 EGR1 + ), among which C 1 S100A4 + macrophages predominated, displayed the strongest proliferative ability, and expressed high levels of inflammatory mediators, including IL1B, CCL3, and CXCL8. Trajectory and regulatory analyses revealed dynamic macrophage differentiation and subtype-specific transcriptional programs. Cell-cell communication analysis identified C1 S100A4 + macrophages as a central signaling hub interacting with endothelial cells, fibroblasts, and immune cells through CXCL, MHC-II, and TNF pathways, thereby suggesting their critical role in post-MI inflammatory remodeling. Conclusion: This study provided a comprehensive single-cell immune atlas of MI and systematically elucidated the heterogeneity, developmental dynamics, transcriptional regulation, metabolic reprogramming, and intercellular communication of macrophage subtypes. C1 S100A4 + macrophages were identified as a key inflammatory population orchestrating immune remodeling after MI. Our findings provide insights into the cellular mechanisms underlying cardiac injury that may offer potential therapeutic targets for precision immunomodulation in MI.
- Open Access
- 24 October 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1709624
Correction: Exposing the cellular situation: findings from single-cell RNA sequencing in breast cancer
- 24 October 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1709624
Open AccessCorrection: Exposing the cellular situation: findings from single-cell RNA sequencing in breast cancer
- Open Access
- 14 October 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-27
Neuron-targeted ROS-responsive liposomes for puerarin delivery remodel ischemic microenvironment via microglial modulation and neurovascular regeneration
Ischemic stroke triggers the “ischemic cascade,” which encompasses vascular injury, oxidative stress, inflammatory responses, and mitochondrial dysfunction, ultimately leading to neuronal death and impaired brain function. Conventional pharmacotherapies have specific limitations, such as being restricted by the blood–brain barrier (BBB), causing systemic side effects, and having poor lesion targeting. To tackle the aforementioned challenges, this study developed PUELipo/R-R, a safe and highly biocompatible liposome nanocarrier modified with reactive oxygen species (ROS)-responsive DSPE-TK-PEG and neuron-targeting RVG29 peptide on the surface, for the precise delivery of puerarin (PUE) to ischemic brain regions and the release of stimuli-responsive drugs. PUE demonstrates the advantage of multi-target regulation in treating ischemic stroke. In a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/r), PUELipo/R-R significantly reduced the volume of cerebral infarction, decreased neuronal death rate, and improved post-stroke motor function. The results of single-cell RNA sequencing (scRNA-seq) revealed that endothelial cells (ECs) and microglia were the cell types with the most significant alterations in the experimental group treated with PUELipo/R-R. Both in vitro and in vivo studies have verified that PUELipo/R-R enhances the expression levels of angiogenesis-related factors, promotes the proliferation, migration, and angiogenesis of cerebrovascular ECs, and improves neuroinflammatory conditions by facilitating the transformation of microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. This novel multi-target therapeutic strategy highlights the potential application of PUELipo/R-R as a possible treatment for ischemic stroke and related disorders.
- 14 October 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-27
Open AccessNeuron-targeted ROS-responsive liposomes for puerarin delivery remodel ischemic microenvironment via microglial modulation and neurovascular regeneration
Ischemic stroke triggers the “ischemic cascade,” which encompasses vascular injury, oxidative stress, inflammatory responses, and mitochondrial dysfunction, ultimately leading to neuronal death and impaired brain function. Conventional pharmacotherapies have specific limitations, such as being restricted by the blood–brain barrier (BBB), causing systemic side effects, and having poor lesion targeting. To tackle the aforementioned challenges, this study developed PUELipo/R-R, a safe and highly biocompatible liposome nanocarrier modified with reactive oxygen species (ROS)-responsive DSPE-TK-PEG and neuron-targeting RVG29 peptide on the surface, for the precise delivery of puerarin (PUE) to ischemic brain regions and the release of stimuli-responsive drugs. PUE demonstrates the advantage of multi-target regulation in treating ischemic stroke. In a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/r), PUELipo/R-R significantly reduced the volume of cerebral infarction, decreased neuronal death rate, and improved post-stroke motor function. The results of single-cell RNA sequencing (scRNA-seq) revealed that endothelial cells (ECs) and microglia were the cell types with the most significant alterations in the experimental group treated with PUELipo/R-R. Both in vitro and in vivo studies have verified that PUELipo/R-R enhances the expression levels of angiogenesis-related factors, promotes the proliferation, migration, and angiogenesis of cerebrovascular ECs, and improves neuroinflammatory conditions by facilitating the transformation of microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. This novel multi-target therapeutic strategy highlights the potential application of PUELipo/R-R as a possible treatment for ischemic stroke and related disorders.
- Open Access
- 6 March 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1539074
Exposing the cellular situation: findings from single cell RNA sequencing in breast cancer
Background: Breast Cancer (BC) ranks among the top three most prevalent cancers globally and stands as the principal contributor to cancer-related fatalities among women. In spite of the substantial occurrence rate of BC, the early stage of this disease is generally regarded as curable. However, intra-tumor heterogeneity presents a formidable obstacle to the success of effective treatment. Method: In this research, single cell RNA sequencing was utilized to dissect the tumor microenvironment within BC. Slingshot, CytoTRACE and Monocle 2 were applied to illustrate the differentiation process of each subpopulation in the pseudotime sequence. To comprehensively comprehend the tumor cells (TCs) in BC, an analysis of upstream transcription factors was carried out via pySCENIC, while downstream pathway enrichment was conducted through KEGG, GO and GSEA. The prognosis model was established based on the bulk data obtained from TCGA and GEO databases. Knock-down experiments were also implemented to explore the function of the transcription factor CEBPD in the TCs. Results: Our in-depth analysis identified eight principal cell types. Notably, TCs were predominantly found within epithelial cells. The classification of TCs further uncovered five unique subpopulations, with one subpopulation characterized by high UGDH expression. This subpopulation was shown to possess distinct metabolic features in metabolism-related investigations. The intricate communication modalities among different cell types were effectively demonstrated by means of CellChat. Additionally, a crucial transcription factor, CEBPD , was identified, which demonstrated a pronounced propensity towards tumors and harbored potential tumor-advancing characteristics. Its role in promoting cancer was subsequently verified through in vitro knock-down experiments. Moreover, a prognostic model was also developed, and a risk score was established based on the genes incorporated in the model. Through comparing the prognoses of different UTRS levels, it was determined that the group with a high UTRS had a less favorable prognosis. Conclusion: These outcomes contributed to the elucidation of the complex interrelationships within the BC tumor microenvironment. By specifically targeting certain subpopulations of TCs, novel treatment strategies could potentially be devised. This study shed light on the direction that future research in BC should take, furnishing valuable information that can be utilized to enhance treatment regimens.
- 6 March 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1539074
Open AccessExposing the cellular situation: findings from single cell RNA sequencing in breast cancer
Background: Breast Cancer (BC) ranks among the top three most prevalent cancers globally and stands as the principal contributor to cancer-related fatalities among women. In spite of the substantial occurrence rate of BC, the early stage of this disease is generally regarded as curable. However, intra-tumor heterogeneity presents a formidable obstacle to the success of effective treatment. Method: In this research, single cell RNA sequencing was utilized to dissect the tumor microenvironment within BC. Slingshot, CytoTRACE and Monocle 2 were applied to illustrate the differentiation process of each subpopulation in the pseudotime sequence. To comprehensively comprehend the tumor cells (TCs) in BC, an analysis of upstream transcription factors was carried out via pySCENIC, while downstream pathway enrichment was conducted through KEGG, GO and GSEA. The prognosis model was established based on the bulk data obtained from TCGA and GEO databases. Knock-down experiments were also implemented to explore the function of the transcription factor CEBPD in the TCs. Results: Our in-depth analysis identified eight principal cell types. Notably, TCs were predominantly found within epithelial cells. The classification of TCs further uncovered five unique subpopulations, with one subpopulation characterized by high UGDH expression. This subpopulation was shown to possess distinct metabolic features in metabolism-related investigations. The intricate communication modalities among different cell types were effectively demonstrated by means of CellChat. Additionally, a crucial transcription factor, CEBPD , was identified, which demonstrated a pronounced propensity towards tumors and harbored potential tumor-advancing characteristics. Its role in promoting cancer was subsequently verified through in vitro knock-down experiments. Moreover, a prognostic model was also developed, and a risk score was established based on the genes incorporated in the model. Through comparing the prognoses of different UTRS levels, it was determined that the group with a high UTRS had a less favorable prognosis. Conclusion: These outcomes contributed to the elucidation of the complex interrelationships within the BC tumor microenvironment. By specifically targeting certain subpopulations of TCs, novel treatment strategies could potentially be devised. This study shed light on the direction that future research in BC should take, furnishing valuable information that can be utilized to enhance treatment regimens.
- Top Cited PapersOpen Access
- 28 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1506225
Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
Background: Osteosarcoma (OS) is one of the most common primary malignant bone tumors, primarily originating from mesenchymal tissue. It is notorious for its high invasiveness, high disability rate, high mortality rate, and poor prognosis. In most primary and metastatic malignant tumors, bone destruction can promote cancer progression, which is closely related to osteoclast activation and the imbalance between osteoblasts and osteoclasts. A large number of studies confirmed that osteoclasts are an important part of OS, which play an active role in destroying bone homeostasis and promoting the progress of OS. Therefore, we conducted a detailed study of osteoclasts at the single cell level, aiming to find new OS therapeutic targets to prevent tumor progression and local spread.Methods: We analyzed the single-cell sequencing data of OS patients and usedMonocle2, Cytotrace, and Slingshot software to analyze the pseudo-sequential trajectory during OS progression. CellChat was used to reveal the communication between cells. PySCENIC was used to identify active transcription factors in osteoclasts. Finally, we further demonstrated the results by RT-qPCR analysis, CCK-8 assay, wound healing assay, Transwell assay, etc.Results: Through the analysis of single-cell sequencing data in OS, we identified a highly specific subgroup, C2MKI67+ Osteoclast. The key signaling pathway APP and the top 1 transcription factor PPARG in this subgroup played essential roles in osteoclast proliferation and differentiation. Given the pivotal role of osteoclasts in OS progression, we speculated that these signaling pathways and transcription factors could emerge as novel therapeutic targets, offering innovative strategies for OS treatment.Conclusion: This study enhanced our understanding of OS and osteoclasts through scRNA-seq. Furthermore, we discovered that PPARG amplifies osteoclast activation and proliferation, resulting in excessive bone resorption and degradation of the bone matrix, thereby creating a favorable environment for tumor cell proliferation and growth. By innovatively targeting PPARG, it affected osteoclast proliferation and thus affected tumor progression; this work offered new insights and directions for the clinical treatment of OS patients.
- 28 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1506225
Top Cited PapersOpen AccessSingle-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
Background: Osteosarcoma (OS) is one of the most common primary malignant bone tumors, primarily originating from mesenchymal tissue. It is notorious for its high invasiveness, high disability rate, high mortality rate, and poor prognosis. In most primary and metastatic malignant tumors, bone destruction can promote cancer progression, which is closely related to osteoclast activation and the imbalance between osteoblasts and osteoclasts. A large number of studies confirmed that osteoclasts are an important part of OS, which play an active role in destroying bone homeostasis and promoting the progress of OS. Therefore, we conducted a detailed study of osteoclasts at the single cell level, aiming to find new OS therapeutic targets to prevent tumor progression and local spread.Methods: We analyzed the single-cell sequencing data of OS patients and usedMonocle2, Cytotrace, and Slingshot software to analyze the pseudo-sequential trajectory during OS progression. CellChat was used to reveal the communication between cells. PySCENIC was used to identify active transcription factors in osteoclasts. Finally, we further demonstrated the results by RT-qPCR analysis, CCK-8 assay, wound healing assay, Transwell assay, etc.Results: Through the analysis of single-cell sequencing data in OS, we identified a highly specific subgroup, C2MKI67+ Osteoclast. The key signaling pathway APP and the top 1 transcription factor PPARG in this subgroup played essential roles in osteoclast proliferation and differentiation. Given the pivotal role of osteoclasts in OS progression, we speculated that these signaling pathways and transcription factors could emerge as novel therapeutic targets, offering innovative strategies for OS treatment.Conclusion: This study enhanced our understanding of OS and osteoclasts through scRNA-seq. Furthermore, we discovered that PPARG amplifies osteoclast activation and proliferation, resulting in excessive bone resorption and degradation of the bone matrix, thereby creating a favorable environment for tumor cell proliferation and growth. By innovatively targeting PPARG, it affected osteoclast proliferation and thus affected tumor progression; this work offered new insights and directions for the clinical treatment of OS patients.
- Open Access
- 24 December 2024
- Published by Elsevier in Translational Oncology
- Vol. 52, 102255
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
- 24 December 2024
- Published by Elsevier in Translational Oncology
- Vol. 52, 102255
Open AccessHeterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 19 (1) , 20241088
Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis
Background: Atherosclerosis is a lipid-driven inflammatory disease characterized by plaque formation in major arteries. These plaques contain lipid-rich macrophages that accumulate through monocyte recruitment, local macrophage differentiation, and proliferation. Objective: We identify the macrophage subsets that are closely related to atherosclerosis and reveal the key pathways in the progression of atherosclerotic disease. Materials and methods: In this study, we characterize the single-cell landscape of atherosclerosis, identifying macrophage subsets closely related to the disease and revealing key pathways in its progression. Using analytical methods like CytoTRACE, Monocle2, Slingshot, and CellChat, we study macrophage differentiation and infer cell trajectory. Results: The 8,417 macrophages were divided into six subtypes, macrophages: C0 C1QC+ macrophages, C1 SPP1+ macrophages, C2 FCN1+ macrophages, C3 IGKC+ macrophages, C4 FCER1A+ macrophages, C5CALD1+ macrophages. The results of gene set enrichment analysis, Monocle2, and Slingshot suggest that C2 FCN1+ macrophages may play an important role in the progression of atherosclerosis. C2 FCN1+ macrophages interact with endothelial cells via CCL, CXCL, APP, and other pathways to regulate the progression of atherosclerosis. Conclusion: We identify a key macrophage subgroup (C2 FCN1+ macrophages) associated with atherosclerosis, which interacts with endothelial cells via CCL, CXCL, APP, and other pathways to regulate disease progression.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 19 (1) , 20241088
Open AccessSingle-cell analysis identified key macrophage subpopulations associated with atherosclerosis
Background: Atherosclerosis is a lipid-driven inflammatory disease characterized by plaque formation in major arteries. These plaques contain lipid-rich macrophages that accumulate through monocyte recruitment, local macrophage differentiation, and proliferation. Objective: We identify the macrophage subsets that are closely related to atherosclerosis and reveal the key pathways in the progression of atherosclerotic disease. Materials and methods: In this study, we characterize the single-cell landscape of atherosclerosis, identifying macrophage subsets closely related to the disease and revealing key pathways in its progression. Using analytical methods like CytoTRACE, Monocle2, Slingshot, and CellChat, we study macrophage differentiation and infer cell trajectory. Results: The 8,417 macrophages were divided into six subtypes, macrophages: C0 C1QC+ macrophages, C1 SPP1+ macrophages, C2 FCN1+ macrophages, C3 IGKC+ macrophages, C4 FCER1A+ macrophages, C5CALD1+ macrophages. The results of gene set enrichment analysis, Monocle2, and Slingshot suggest that C2 FCN1+ macrophages may play an important role in the progression of atherosclerosis. C2 FCN1+ macrophages interact with endothelial cells via CCL, CXCL, APP, and other pathways to regulate the progression of atherosclerosis. Conclusion: We identify a key macrophage subgroup (C2 FCN1+ macrophages) associated with atherosclerosis, which interacts with endothelial cells via CCL, CXCL, APP, and other pathways to regulate disease progression.